medigraphic.com
Órgano Oficial del Instituto Nacional de Pediatría

2009, Number 1

<< Back Next >>

Acta Pediatr Mex 2009; 30 (1)

Renal biopsy

León-Bojorge B

Language: Spanish
References: 30
Page: 36-53
PDF size: 108.01 Kb.


Text Extraction

No abstract


REFERENCES

  1. Silva GF, D’Agati DV, Nadasdy T. Renal biopsy interpretation. Churchill Livingstone, Inc.: 1996.

  2. Agnes BA, Kashgarian M. Diagnostic Atlas of Renal Pathology. Elsevier Sanders: 2005.

  3. Sebire JN. An approach to the paediatric renal biopsy. Curr Diag Pathol 2007;13:43-53.

  4. D’Agati V, Jennette JC, Silva GF. An approach to the pathologic diagnosis of glomerulonephritis. In: Atlas of nontumor pathology. Non-Neoplastic kidney diseases. American Registry of Pathology. Washington, DC: Armed Forces Institute of Pathology; 2005.

  5. Pirani CL, Salinas-Madrigal L.. Evaluation of percutaneous renal biopsy. In Sommers SC (Ed): Kidney Pathology Decennial 1966-1975. E Norwalk, CT: Appleton-Century-Crofts; 1975. p.109.

  6. Wagrowska-Danilewicz M, Danilewicz M. Current position of electron microscopy In the diagnosis of glomerular disease. Pol J Pathol 2006;58:87-92.

  7. Patrakka J, Lahdenkari AT, Koskimies O, Holmberg C, Wartiovaara J, Jalanko H. The number of podocyte slit is decreased in minimal change nephrotic syndrome. Pediatr Res 2002;52:349-55.

  8. Wang S, Kim JH, Moon KC, Hong HK, Lee HS. Cell-cycle mechanisms involved in podocyte proliferation in cellular lesion of focal segmental glomerulosclerosis. Am J Kidney Dis 2006;43:19-27.

  9. Kumar J, Gulati S, Sharma AP, Sharma RK, Gupta RK. Histopathological spectrum of childhood nephrotic syndrome in Indian children. Pediatr Nephrol 2003;18:657-60.

  10. Srivastava T, Garola RE, Singh HK. Cell-cycle regulatory proteins in the podocyte in collapsing glomerulopathy in children. Kidney Int 2006;70:529-35.

  11. Thomer PS. Alport syndrome and thin basement membrane nephropathy. Nephron Clin Pract 2007;106:c82-88.

  12. Ashton C, Frank R, Vento S, Crosby V, Chandra M, Gauthier B, Valderrama E, Trachman H. Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcome. BMC Nephrol 2007;8:11-14.

  13. Fukuma Y, Hisano S, Niimi K, Tsuru N, Kaku Y, Hatae K, Kiyoshi Y, Mitudome A, Iwasaki H. Clinicopathologic correlation of C1q nephropathy in children. Am J Kidney Dis 2006;47:412-18.

  14. Kamioka I, Nozu K, Fujita T, Kaito H, Tanaka R, Yoshiya K, Iijima K, Nakanishi K, Yoshikawa N, Matsuo M. Prognosis and pathological characteristics of fi ve children with non-Shiga toxin-mediated hemolytic uremic syndrome. Pediatr Int 2007;49:196-201.

  15. Carbajal Rodríguez L, Muñoz Gómez JC, De León Bojorge B, Pablos Hach JI, Loredo Abdala A. Evaluación nefrológica en pacientes con lupus eritematoso sistémico. Rev Mex de Pediatría 1995;62:141-8.

  16. De León Bojorge B, Salinas Madrigal L, Asato Higa C, Rosenberg H, López A. Seminario de Patología glomerular. Seminario SLAP. Patología (Méx) 1996;43:139-51.

  17. De León Bojorge B, Tomas L. Lupus Eritematoso Sistémico en niños. Hallazgos anatomopatológicos en 30 autopsias. Patología 1994; 32:S-3.

  18. Weening JJ, D’Agati VD, Schwartz MM. Classifi cation of glomerulonephritis in systemic lupus erythematous revisited. Kidney Int 2004;65:521-30.

  19. Markowitz GS, D’Agati VD. The ISN/RPS 2003 classifi cation of lupus nephritis: An assessment at 3 years Kidney Int 2007;71:491-5.

  20. Zappitelli M, Duffy MC, Bernard Ch, Gupta RI. Evaluation of activity, chronicity and tubulointerstitial indices in childhood lupus nephritis. Pediatr Nephrol (serial on line) 2007.

  21. Yamazaki-Nakashimada M, Zaltzman-Girshevich S, Garcia de la Puente S, De León-Bojorge B, Espinosa-Padilla S, Saez-de-Ocariz M, et al. Hiper-IgE syndrome and autoimmunity in Mexican children. Pediatr Nephrol 2006;21:1200-95.

  22. Lee SH, Lee SM, Lee MS, Lee YS, Lee SE, Lee YE, Park YS, Han SJ, Kim S, Lee SJ. Histological grading IgA nephropathy predicting renal outcome: revisiting H. S. Lee’s glomerular grading system. Nephrol Dial Transplant 2005;20:324-8.

  23. Desinor-Monpoint OI, García de la Puente S, De León Bojorge B, Pablos Hoch JL, Zaltzman GS. Nefropatía de la púrpura de Henoch-Schönlein. Bol Med Hosp Infant Mex 1991;48:730-5.

  24. García-de la Puente S, Orozco-Loza IL, Zaltzman-Girshevich S, De León-Bojorge B. Prognostic factors in children with membranoproliferative glomerulonephritis type I. Pediatr Nephrol 2008;23:929-35.

  25. Mejía Hernández C, Alvarez Mendoza A, De León Bojorge B. Takayasu's arteritis coexisting with Wegener's granulomatosis in a teenager with renal insuffi ciency: Case report. Pediatr Develop Pathol 1999;2:1-5.

  26. Appel BG, Cook TH, Hageman G, Jennette C, Kashgarian M, Kirschfi nk M, et al. Membranoproliferative glomerulonephritis type II (Dense deposit disease): An update. J Am Soc Nephrol 2005;16:1392-404.

  27. Walker PD, Ferrario F, Joh K, Bosbit SM. Dense deposits disease is not a membranoproliferative glomerulonephritis. Mod Pathol 2007;20:605-17.

  28. Racusen CL, Solez K, Colvin BR, Bonsib MS, Castro CM, Cavallo T, Croker PB, Demetris JA, Drachenberg BC, Fogo BA, Furness P, Garner WL, Gibson WI, Glotz D, Goldberg CJ, Grande J, Halloran FP, Hansen EH, Hartley B, Hayry JP, Hill MC, et al. The Banff’ 97 working classifi cation of renal allograft pathology. Kid Int 1999;55:713-23.

  29. Solez K, Colvin RB, Racusen LC, Sis b, Hallroran PF, Birk PE, Campell PM, Cascalho M, Collis AB, Demetris PC, Drachenberg CB, Gibson IW, Grimm PC, Hass M, et al. Banff ’05 meeting report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (“CAN”). Am J Transplant 2007;7:518-26.

  30. Smith JM, Dharnidharka VR, Talley L, Martz K, McDonald RA. BK virus nephropathy in pediatric renal transplant recipients: an analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry. Clin J Am Soc Nephrol 2007;2:1037-42.




2020     |     www.medigraphic.com